How BPC-157 Works: Mechanism and Pharmacology
How BPC-157 works: its target and mechanism as the sources state them, how long it acts, and what is still unknown.
- Class
- Gastric pentadecapeptide
- FDA status
- Not approved
- Off Category 2, 15 Apr 2026
- Routes studied
- intra-articular injection (BPC 157 alone or with TB4); injection around the inflamed bladder area during cystoscopy; intravenous infusion over one hour
- Half-life
- less than 30 min
- IV and IM (single and repeated), rat, beagle dog · Frontiers in pharmacology 2022, PMID 36588717
How long it acts
Half-life values from FDA labels and published studies, by route. Animal values are labelled and do not describe people.
| Route | Half-life | Measured in | Source |
|---|---|---|---|
| IV and IM (single and repeated) | less than 30 min | Animal · rat, beagle dog | Frontiers in pharmacology 2022, PMID 36588717 |
| not stated (review summary) | less than 30 minutes | Animal · review of preclinical data | HSS journal 2025, PMID 40756949 |
Full detail, including drug-testing windows, is on the BPC-157 half-life page.
Where the sequence comes from and what pathway has been named
The 15-amino-acid sequence is a fragment of a protein first isolated from human gastric juice.[3]
In rat tendon fibroblasts grown in the lab, the effect on cell migration is proposed to run through the FAK-paxillin pathway.[3]
The systematic review says the animal literature points to growth hormone receptor expression, growth and angiogenesis pathways, and fewer inflammatory cytokines.[2]
Blood vessels and the nitric oxide system in rats
In a rat model of colon ischemia, the authors conclude the peptide restored blood supply and that the nitric oxide system is involved.[4]
A different rat fistula study found the benefits did not change when nitric oxide generation was blocked, so the NO role is not settled.[5]
In rats with drug-induced heart attack, the proposed mechanism is counteraction of an occlusion-like syndrome.[6]
In rat glaucoma the claimed mechanism is faster recruitment of collateral vessels after vein cauterization.[7]
Liver and nerve mechanisms from rodent work
In irradiated mice and rat liver cells, silencing of a transcription factor called KLF4 removed the protection.[8]
In rats with spinal cord injury, a single early injection was followed by less axon loss and motor-neuron loss.[9]
Why the half-life matters, and what is unknown
In rats and beagle dogs the unchanged peptide was cleared quickly, which is the only cached pharmacokinetic measurement.[1]
The same review cannot name a human mechanism study: it counted 1 clinical study among 36.[2]
Related peptides
Common questions
How long does BPC-157 act in the body?
The half-life values we found are less than 30 min (IV and IM (single and repeated), rat, beagle dog); less than 30 minutes (not stated (review summary), review of preclinical data). A half-life is how long the amount in the body takes to fall by half; it is not the same as how long an effect lasts.
Does BPC-157 work?
The review concludes that it shows promise based on level IV and V evidence, which are the weakest tiers of study design.[2]
How long does BPC-157 take to work?
No cached human study reports a time course; in the rat tendon study, assessments were made on days 1, 4, 7, 10 and 14.[10]
More on BPC-157
Sources
- 1Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157, a potential drug for treating various wounds, in rats and dogs.Frontiers in pharmacology · 2022PMID 36588717Accessed 2 Oct 2026
- 2Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review.HSS journal : the musculoskeletal journal of Hospital for Special Surgery · 2025PMID 40756949Accessed 2 Oct 2026
- 3The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration.Journal of applied physiology (Bethesda, Md. : 1985) · 2011PMID 21030672Accessed 2 Oct 2026
- 4Stable gastric pentadecapeptide BPC 157 in the treatment of colitis and ischemia and reperfusion in rats: New insights.World journal of gastroenterology · 2017PMID 29358856Accessed 2 Oct 2026
- 5Pentadecapeptide BPC 157, in clinical trials as a therapy for inflammatory bowel disease (PL14736), is effective in the healing of colocutaneous fistulas in rats: role of the nitric oxide-system.Journal of pharmacological sciences · 2008PMID 18818478Accessed 2 Oct 2026
- 6Stable Gastric Pentadecapeptide BPC 157 May Counteract Myocardial Infarction Induced by Isoprenaline in Rats.Biomedicines · 2022PMID 35203478Accessed 2 Oct 2026
- 7Stable Gastric Pentadecapeptide BPC 157 Therapy of Rat Glaucoma.Biomedicines · 2021PMID 35052769Accessed 2 Oct 2026
- 8Pentadecapeptide BPC 157 efficiently reduces radiation-induced liver injury and lipid accumulation through Kruppel-like factor 4 upregulation both in vivo and in vitro.Life sciences · 2022PMID 36228773Accessed 2 Oct 2026
- 9Stable gastric pentadecapeptide BPC 157 can improve the healing course of spinal cord injury and lead to functional recovery in rats.Journal of orthopaedic surgery and research · 2019PMID 31266512Accessed 2 Oct 2026
- 10Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2003PMID 14554208Accessed 2 Oct 2026
Found an error? Report a correction.